...
首页> 外文期刊>International Journal of Nanomedicine >Synthesis and characterization of bioactive conjugated near-infrared fluorescent proteinoid-poly(L-lactic acid) hollow nanoparticles for optical detection of colon cancer
【24h】

Synthesis and characterization of bioactive conjugated near-infrared fluorescent proteinoid-poly(L-lactic acid) hollow nanoparticles for optical detection of colon cancer

机译:用于结肠癌光学检测的生物活性共轭近红外荧光类蛋白-聚(L-乳酸)空心纳米粒子的合成与表征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract: Colon cancer is one of the major causes of death in the Western world. Early detection significantly improves long-term survival for patients with colon cancer. Near-infrared (NIR) fluorescent nanoparticles are promising candidates for use as contrast agents for tumor detection. Using NIR offers several advantages for bioimaging compared with fluorescence in the visible spectrum: lower autofluorescence of biological tissues and lower absorbance and, consequently, deeper penetration into biomatrices. The present study describes the preparation of new NIR fluorescent proteinoid-poly(L-lactic acid) (PLLA) nanoparticles. For this purpose, a P(EF-PLLA) random copolymer was prepared by thermal copolymerization of L-glutamic acid (E) with L-phenylalanine (F) and PLLA. Under suitable conditions, this proteinoid-PLLA copolymer can self-assemble to nanosized hollow particles of relatively narrow size distribution. This self-assembly process was used for encapsulation of the NIR dye indocyanine green. The encapsulation process increases significantly the photostability of the dye. These NIR fluorescent nanoparticles were found to be stable and nontoxic. Leakage of the NIR dye from these nanoparticles into phosphate-buffered saline containing 4% human serum albumin was not detected. Tumor-targeting ligands such as peanut agglutinin and anticarcinoembryonic antigen antibodies were covalently conjugated to the surface of the NIR fluorescent P(EF-PLLA) nanoparticles, thereby increasing the fluorescent signal of tumors with upregulated corresponding receptors. Specific colon tumor detection by the NIR fluorescent P(EF-PLLA) nanoparticles was demonstrated in a chicken embryo model. In future work, we plan to extend this study to a mouse model, as well as to encapsulate a cancer drug such as doxorubicin within these nanoparticles for therapeutic applications.
机译:摘要:结肠癌是西方世界主要的死亡原因之一。早期发现可显着提高结肠癌患者的长期生存率。近红外(NIR)荧光纳米粒子有望用作肿瘤检测的造影剂。与可见光谱中的荧光相比,使用近红外光谱为生物成像提供了许多优势:生物组织的自发荧光降低,吸收率降低,从而更深入地渗透到生物基质中。本研究描述了新的近红外荧光类蛋白-聚(L-乳酸)(PLLA)纳米粒子的制备。为此,通过L-谷氨酸(E)与L-苯丙氨酸(F)和PLLA的热共聚制备P(EF-PLLA)无规共聚物。在合适的条件下,这种类蛋白-PLLA共聚物可以自组装为尺寸分布相对较窄的纳米级中空颗粒。此自组装过程用于NIR染料吲哚菁绿的封装。包封过程显着提高了染料的光稳定性。发现这些NIR荧光纳米颗粒是稳定且无毒的。未检测到NIR染料从这些纳米颗粒泄漏到含有4%人血清白蛋白的磷酸盐缓冲液中。将靶向肿瘤的配体(例如花生凝集素和抗癌胚抗原抗体)共价偶联至NIR荧光P(EF-PLLA)纳米粒子的表面,从而增加相应受体上调的肿瘤的荧光信号。通过NIR荧光P(EF-PLLA)纳米粒子的特定结肠肿瘤检测在鸡胚模型中得到证明。在未来的工作中,我们计划将该研究扩展到小鼠模型,并在这些纳米颗粒中封装诸如阿霉素之类的抗癌药物,以用于治疗应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号